Bectas Therapeutics is a biotech company that develops monoclonal antibody therapies for cancer.
Bectas Therapeutics has raised $5.5M in total funding. The most recent round was Seed. The last funding was announced in October 2024.
Bectas Therapeutics is headquartered in Houston, United States.
Bectas Therapeutics is a biotech company that develops monoclonal antibody therapies for cancer.
Bectas Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Bectas Therapeutics — Funding & Investors." VCBacked, October 9, 2024, https://www.vcbacked.co/company/bectas-therapeutics. Accessed August 14, 2026.
VCBacked. (2024). Bectas Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/bectas-therapeutics
{{cite web |title=Bectas Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/bectas-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated